May 2023
1. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
   Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
   PLoS Med. 2023;20:e1004237.
   

   >> Share

   
   
2. BALIASHVILI D, Blumberg HM, Gandhi NR, Averhoff F, et al
   Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
   PLoS Med. 2023;20:e1004121.
   

   >> Share

   
   April 2023
3. PAIXAO ES, Ferreira AJ, Dos Santos IO, Rodrigues LC, et al
   Mortality in children under 5 years of age with congenital syphilis in Brazil: A nationwide cohort study.
   PLoS Med. 2023;20:e1004209.
   

   >> Share

   
   March 2023
4. PROCTER SR, Goncalves BP, Paul P, Chandna J, et al
   Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.
   PLoS Med. 2023;20:e1004068.
   

   >> Share

   
   
5. MEMIRIE ST, Tolla MT, Rumpler E, Sato R, et al
   Out-of-pocket expenditures and financial risks associated with treatment of vaccine-preventable diseases in Ethiopia: A cross-sectional costing analysis.
   PLoS Med. 2023;20:e1004198.
   

   >> Share

   
   January 2023
6. MARLEY G, Zou X, Nie J, Cheng W, et al
   Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions.
   PLoS Med. 2023;20:e1004091.
   

   >> Share

   
   
7. PORTNOY A, Clark RA, Quaife M, Weerasuriya CK, et al
   The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
   PLoS Med. 2023;20:e1004155.
   

   >> Share

   
   
8. WAHEDI K, Zenner D, Flores S, Bozorgmehr K, et al
   Mandatory, voluntary, repetitive, or one-off post-migration follow-up for tuberculosis prevention and control: A systematic review.
   PLoS Med. 2023;20:e1004030.
   

   >> Share

   
   July 2022
9. BROTHERS TD, Lewer D, Jones N, Colledge-Frisby S, et al
   Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.
   PLoS Med. 2022;19:e1004049.
   

   >> Share

   
   June 2022
10. NSENGIYUMVA NP, Campbell JR, Oxlade O, Vesga JF, et al
    Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    PLoS Med. 2022;19:e1004032.
    

    >> Share

    
    May 2022
11. 
    Call for Papers: PLOS Medicine Special Issue on Bacterial Antimicrobial Resistance-Surveillance and Prevention.
    PLoS Med. 2022;19:e1004014.
    

    >> Share

    
    
12. NYAMWAYA DK, Otiende M, Mwango L, Kariuki SM, et al
    Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.
    PLoS Med. 2022;19:e1003994.
    

    >> Share

    
    
13. QIAN G, Toizumi M, Clifford S, Le LT, et al
    Association of pneumococcal carriage in infants with the risk of carriage among their contacts in Nha Trang, Vietnam: A nested cross-sectional survey.
    PLoS Med. 2022;19:e1004016.
    

    >> Share

    
    March 2022
14. FOSTER N, Nguyen HV, Nguyen NV, Nguyen HB, et al
    Social determinants of the changing tuberculosis prevalence in Viet Nam: Analysis of population-level cross-sectional studies.
    PLoS Med. 2022;19:e1003935.
    

    >> Share

    
    February 2022
15. YANG C, Sobkowiak B, Naidu V, Codreanu A, et al
    Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis.
    PLoS Med. 2022;19:e1003933.
    

    >> Share

    
    January 2022
16. FOO C, Shrestha P, Wang L, Du Q, et al
    Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review.
    PLoS Med. 2022;19:e1003899.
    

    >> Share

    
    
17. HOCKING JS, Wood A, Temple-Smith M, Braat S, et al
    The impact of removing financial incentives and/or audit and feedback on chlamydia testing in general practice: A cluster randomised controlled trial (ACCEPt-able).
    PLoS Med. 2022;19:e1003858.
    

    >> Share

    
    December 2021
18. SEMITALA FC, Kadota JL, Musinguzi A, Nabunje J, et al
    Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
    PLoS Med. 2021;18:e1003875.
    

    >> Share

    
    November 2021
19. HARDY M, Samuela J, Kama M, Tuicakau M, et al
    Community control strategies for scabies: A cluster randomised noninferiority trial.
    PLoS Med. 2021;18:e1003849.
    

    >> Share

    
    September 2021
20. WEN SCH, Ezure Y, Rolley L, Spurling G, et al
    Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003787.
    

    >> Share

    
    
21. HUYNH BT, Kermorvant-Duchemin E, Chheang R, Randrianirina F, et al
    Severe bacterial neonatal infections in Madagascar, Senegal, and Cambodia: A multicentric community-based cohort study.
    PLoS Med. 2021;18:e1003681.
    

    >> Share

    
    August 2021
22. CHAN J, Gidding HF, Blyth CC, Fathima P, et al
    Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.
    PLoS Med. 2021;18:e1003733.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share